Compound Profile: CLENBUTEROL 100 La Pharma
Clenbuterol 100 La Pharma is a pharmaceutical-grade beta-2 adrenergic agonist manufactured to laboratory standards for metabolic research applications. This compound belongs to the beta-agonist class of substances and demonstrates selective affinity for beta-2 adrenergic receptors in cellular models. Research scientists at Stroid UK Shop utilise this preparation to investigate cellular energy expenditure, metabolic signalling pathways, and sympathomimetic responses in controlled laboratory environments. The La Pharma formulation provides consistent dosing for reproducible research outcomes.
Research Applications and Mechanisms
Laboratory studies investigate clenbuterol’s mechanism as a selective beta-2 adrenergic receptor agonist, examining its effects on adenylyl cyclase activation and subsequent cAMP elevation in cellular models. Research applications focus on metabolic pathway modulation, thermogenic responses, and lipolytic enzyme activation in adipocyte cultures. Scientists studying fat burner compounds analyse this compound’s interaction with protein kinase A signalling cascades and its influence on hormone-sensitive lipase activity. Additional research examines bronchodilator properties through smooth muscle relaxation mechanisms in respiratory tissue models. Comparative studies with SARMs compounds explore different metabolic modulation approaches, while investigations alongside peptide research chemicals examine synergistic metabolic effects in cellular systems.
Specifications and Research Data
| Active Compound | Clenbuterol Hydrochloride |
|---|---|
| Concentration | 100mcg per tablet |
| CAS Number | 21898-19-1 |
| Molecular Formula | C₁₂H₁₈Cl₂N₂O·HCl |
| Molecular Weight | 313.65 g/mol |
| Manufacturer | La Pharma |
| Storage Requirements | Room temperature, dry environment |
| Research Classification | Beta-2 adrenergic agonist |
Laboratory Compliance and Research Notice
This clenbuterol preparation is manufactured exclusively for in-vitro laboratory research applications and scientific investigation purposes. Research institutions and qualified laboratories should store this compound according to specified environmental conditions and handle using appropriate laboratory safety protocols. All research activities must comply with institutional guidelines for beta-agonist compound studies. This product is not approved for human consumption, therapeutic use, or any application outside controlled laboratory research environments. Researchers must maintain proper documentation and follow applicable regulations governing beta-2 agonist research compounds in their jurisdiction.
